Medtronic Refutes Claims Of Gaps In Infuse Adverse-Event Reporting
This article was originally published in Clinica
Executive Summary
Medtronic has lashed back at a media news report claiming the medical device giant did not properly report adverse events during a 206-2008 chart review of its Infuse biologic-based spinal bone growth product.